Oral Cancer Conference 2019

Currently, oral and oropharyngeal squamous cell carcinoma (OSCC) is the 6th most common cancer world-wide, and is associated with poor survival rates. This interactive, case-based symposium is designed to update medical and dental colleagues on the latest advances in the diagnosis, treatment, and postsurgical management of oral cavity and head and neck cancer.

The poor survival rate of OSCC is primarily attributed to delays in diagnosis, and therefore, advanced staging at onset. It is imperative to diagnosis lesions early, although early detection strategies, while emerging, are not yet part of the standard of care. Community clinicians, including dentists and otolaryngologists, are on the front line for the early detection and surveillance of this disease, as well as in managing the chosen medical treatment and its impact for their patients.


Oral Malignant and Potentially Malignant Lesions

Billy Ballard, DDS, MD, and M. Abraham Kuriakose, MD, put into perspective the essence of oral cancer. At the current rate 53,000 new cases of oral cancer will be diagnosed this year and of that 11,000 of those patients will die from that ...
Billy Ballard, M.D., D.D.S.

Billy Ballard, M.D., D.D.S.

Postdoctoral Fellowship: Roswell Park Memorial Institute
M. Abraham Kuriakose, MD

M. Abraham Kuriakose, MD

Director, Translational Research for Head & Neck / Plastic & Reconstructive Surgery

Guidelines in the Management of Oral Cancer

Michael R. Markiewicz, MD, shares an informative look at the new NCCN staging guidelines, options for managing the neck, and adjuvant treatment for oral cancer.
Michael R. Markiewicz, DDS, MD, MPH, FACS

Michael R. Markiewicz, DDS, MD, MPH, FACS

Consulting Physician, Roswell Park Comprehensive Cancer Center
Co-Director, Cleft and Craniofacial Team, Craniofacial Center of Western New York

Dental Care of Oral Cancer Patients

As part of the Oral Cancer Conference 2019, Heidi Crow, DDS, shares dental concerns for patients with oral cancer. This lecture covers pre-treatment, peri-treatment, and post treatment.
Heidi Crow, DDS, MD

Heidi Crow, DDS, MD

Interim Clinical Chief, Roswell Park Comprehensive Cancer Center
Interim Clinical Chief, Dentistry and Maxillofacial Prosthetics Department

Radiation and Chemotherapy Mucositis

Anurag Singh, MD, has one important message. When you see one of his patients with Radiation Mucositis, “Do not prescribe them anything.” This lecture will cover the incidence/etiology, supportive care, and lastly a few new directions in treatment.
Anurag Singh, MD

Anurag Singh, MD

Professor of Oncology, Department of Radiation Medicine at Roswell Park Comprehensive Cancer Center

Osteoradionecrosis and Medication-Related Osteonecrosis

Keith Kirkwood, DDS, PhD, will explain how to understand the similarities and differences between osteoradionecrosis of the jaw and medication related osteonecrosis of the jaw. Lastly, how to summarize the ration-induced fibroatrophic ...
Keith Kirkwood, DDS, PhD

Keith Kirkwood, DDS, PhD

Department of Dentistry & Maxillofacial Prosthetics, Roswell Park Comprehensive Cancer Center

Mandible and Maxilla Reconstruction

Can Ozturk, MD, discusses common indications for mandibular reconstruction as well as reconstruction goals.
Can Ozturk, MD

Can Ozturk, MD

Department of Head & Neck/Plastic and Reconstructive Surgery, Roswell Park Comprehensive Cancer Center

Maxillary Reconstruction

Ryan McSpadden, MD, discusses maxillary reconstruction shares his experience and insights into the process of how to get everything working again after treatment.
Ryan McSpadden, MD

Ryan McSpadden, MD

Head and Neck, Plastic and Reconstructive Surgery, Roswell Park Comprehensive Cancer Center

Speech and Swallowing Rehabilitation

Lindsay Wachowiak, SLP MA and Amy Sumbrum, CCC-SLP, share insights into speech and swallowing rehabilitation after receiving treatment for oral cancer.
Lindsay Wachowiak, SLP MA

Lindsay Wachowiak, SLP MA

Speech-Language Pathologist

Malnutrition Risk and Sarcopenia

Mary Platek, PhD, CDN, talks about the importance of the nutritional status of head and neck cancer patients.
Mary Platek, PhD, MS

Mary Platek, PhD, MS

Assistant Professor of Oncology, Roswell Park Comprehensive Cancer Center

Function and Frailty Status Pre- and Post- Treatment for Oral Cancer

Andrew Ray, PhD, PT, takes a look at the functionality and frailty of patients who are malnourished, have sarcopenia, or cachexia.
Andrew Ray, PT, PhD

Andrew Ray, PT, PhD

Associate Professor of Oncology, Roswell Park Comprehensive Cancer Center